Mental Heal

Antipsychotic Treatment for Schizophrenia and Mood Disorders

Health Tech & Life Sciences
Non Active, Jan 2016
Seed Tel Aviv-Yafo, Israel Founded 2012
LinkedIn
Last updated 2026-06-18
Total raised
Last:
Stage
Seed
Founded
2012
Headcount
2
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

Mental-Heal by Abital is developing a novel oral antipsychotic drug, PGW-5, for the treatment of schizophrenia and bipolar disorder. PGW-5 is a neuroleptic, multi-target agent that is potentially effective for the treatment of schizophrenia symptoms and other cognitive deficits and mood disorders. The possible mechanisms underlying the differential effects of the drugs may involve the brain glutamate NMDA (N-Methyl-D-Aspartate receptor) system as well as neurotrophic factors and food intake regulating peptides. Early scientific work in animal models has shown that PGW-5 has anxiolytic and antidepressant activity and improves impaired social performance in PCP-treated mice.

Funding history · 1 round · — total

Date unknown

Q&A

What is Mental Heal's primary focus?
Mental Heal is developing PGW-5, a novel oral antipsychotic drug for the treatment of schizophrenia and bipolar disorder.
What is the current status of Mental Heal?
Mental Heal is currently inactive, as of January 2016.
When was Mental Heal founded?
Mental Heal was founded in October 2012.
How many employees does Mental Heal have?
Mental Heal has 1-10 employees.
What is Mental Heal's current product stage?
Mental Heal's product is in the R&D stage.
Which sector does Mental Heal primarily operate in?
Mental Heal's primary sector is Health Tech & Life Sciences.
Has Mental Heal received any funding?
Mental Heal received funding from the Office of the Chief Scientist and Abital.
Does Mental Heal hold any patents?
Yes, Mental Heal holds 1 patent.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Biologicals
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2B

Highlights

1 Patents

Tags

psychiatrypharmaceuticalsmental-healthschizophreniatreatments
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)